[1] Harris NL, Jaffe ES, Diebold J, et al.The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the clinical advisory committee meeting, Airlie House, Virginia, November, 1997[J].Ann Oncol, 1999, 10(12): 1419-1432.
[2] Hyman GA, Wolff M.Malignant lymphomas of the salivary glands. Review of the literature and report of 33 new cases, including four cases associated with the lymphoepithelial lesion[J]. Am J Clin Pathol, 1976, 65(4): 421-438.
[3] Tiplady CW, Taylor PR, White J, et al.Lymphoma presenting as a parotid tumour: a population-based study of diagnosis, treatment and outcome on behalf of the Scotland and Newcastle Lymphoma Group[J]. Clin Oncol(R Coll Radiol), 2004, 16(6): 414-419.
[4] Karimi-Yazdi A, Motiee-Langroudi M, Saedi B, et al.Diagnostic value of fine-needle aspiration in head and neck lymphoma: a cross-sectional study[J]. Indian J Otolaryngol Head Neck Surg, 2014, 66(Suppl 1): 277-280.
[5] Freeman C, Berg JW, Cutler SJ.Occurrence and prognosis of extranodal lymphomas[J]. Cancer, 1972, 29(1): 252-260.
[6] Öneç B, Koç A, Ünlü EN, et al.T-cell lymphoma presenting with auricular and parotid gland involvement[J]. Turk J Haematol, 2016, 33(1): 75-76.
[7] Lieder A, Franzen A.Management of primary malignant lymphoma of the parotid gland in a series of seven hundred and forty‐five patients[J]. Clin Otolaryngol, 2017, 42(2): 477-480.
[8] Yanagawa N, Osakabe M, Furuse H, et al.Peripheral T-cell lymphoma arising from an intraglandular lymph node in the parotid gland: A case report and literature review[J]. Pathol Int, 2012, 62(1): 60-64.
[9] Scully C, Eveson JW, Witherow H, et al.Oral presentation of lymphoma: case report of T-cell lymphoma masquerading as oral Crohn's disease, and review of the literature[J]. Eur J Cancer B Oral Oncol, 1993, 29(3): 225-229.
[10] Gete GP, Almodóvar AC, García AG, et al.Parotid tumours: correlation between fine needle aspiration biopsy and histological findings[J]. Acta Otorrinolaringol Esp, 2006, 57(6): 279-282.
[11] Wyss E, Lgyi E, Ghadjar P, et al.Diagnosis and treatment outcomes for patients with lymphoma of the parotid gland[J]. Laryngoscope, 2013, 123(3): 662-669.
[12] Alphs HH, Eisele DW, Westra WH.The role of fine needle aspiration in the evaluation of parotid masses[J]. Curr Opin Otolaryngol Head Neck Surg, 2006, 14(2): 62-66.
[13] Raine C, Saliba K, Chippindale AJ, et al.Radiological imaging in primary parotid malignancy[J]. Br J Plast Surg, 2003, 56(7): 637-643.
[14] Bagirath PV, Kumar JV, Arvind UD, et al.Aggressive extranodal peripheral T-cell non-Hodgkin's lymphoma: A rare case report and review[J]. J Oral Maxillofac Pathol, 2014, 18(1): 80-83.
[15] Vose J, Armitage J, Weisenburger D.International peripheral T-cell and natural killer/T- cell lymphoma study:Pathology findings and clinical outcomes[J]. J Clin Oncol, 2008, 26(25): 4124-4130.
[16] Wen JY, Li M, Li X, et al.Efficacy and tolerance of pegaspargasebased chemotherapy in patients with nasal- type extranodal NK/ Tcelllymphoma: a pilot study[J]. Asian Pac J Cancer Prev, 2014, 15(15): 6275-6281.
[17] Laribi K, Alani M, Truong C, et al.Recent advances in the treatment of peripheral T-ell lymphoma[J]. Oncologist, 2018, 23(9): 1039-1053.
[18] Yaprak N, Temel IC, Derin AT, et al.Diagnosis and treatment of malignant lymphomas of parotid gland[J]. Kulak Burun Bogaz Ihtis Derg, 2015, 25(6): 346-349.
[19] Lee HG, Lee JY, Song JM.Malignant lymphoma on parotid gland: a clinical case[J]. J Korean Assoc Oral Maxillofac Surg, 2017, 43(2): 138-143.
[20] Ellin F, Landström J, Jerkeman M, et al.Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish lymphoma registry[J]. Blood, 2014, 124(10): 1570-1577. |
